E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/16/2009 in the Prospect News PIPE Daily.

New Issue: IGI takes in $6 million in private placement

By Devika Patel

Knoxville, Tenn., March 16 - IGI Laboratories, Inc. said it completed a $6 million private placement of securities.

The deal consisted of 253 series B-1 convertible preferred shares and $4.48 million in secured convertible promissory notes along with an unspecified number of warrants.

Each preferred is convertible into 14,634 common shares, for an implied common stock conversion price of $0.41 per share.

Upon stockholder approval of the transaction, the promissory notes will convert into 747 series B-1 convertible preferreds. If stockholder approval is not obtained, the promissory notes will become due and the warrants will become exercisable for 747 preferreds at $6,000.00 per preferred.

Rockport Venture Securities, LLC was the agent.

Proceeds will be used to support pharmaceutical product development efforts, as well as other general corporate purposes.

IGI is a pharmaceutical company based in Hillside, N.J.

Issuer:IGI Laboratories, Inc.
Issue:Series B-1 convertible preferred stock, secured convertible promissory notes
Amount:$6 million
Warrants:Yes (for 747 preferreds, but exercisable only under certain conditions)
Warrant strike price:$6,000.00
Agent:Rockport Venture Securities, LLC
Settlement date:March 16
Stock symbol:Amex: IG
Stock price:$0.58 at close March 13
Market capitalization:$10.1 million
Series C convertible preferred stock
Amount:$1,518,000
Shares:253
Conversion price:$0.41
Conversion ratio:Into 14,634 shares
Convertible promissory notes
Amount:$4,482,000
Conversion ratio:Into 747 series B-1 convertible preferred shares

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.